Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer
Clinical trial NCT04666129 · COMPLETED
Trial details
- NCT number
- NCT04666129
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-18
- Primary completion
- 2024-05-28
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.